Publications by authors named "Charlie Reavill"

Claim this Profile
T
The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.
Ian P Holmes, Richard J Blunt, Olivier E Lorthioir, Stephen M Blowers, Andy Gribble, Charlie Reavill

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040.
Eric Southam, Jackie Cilia, Jane E Gartlon, Marie L Woolley, Laurent P Lacroix, Charlie Reavill

Psychopharmacology (Berl)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat.
Marie L Woolley, Kerry A Waters, Charlie Reavill, Sharlene Bull, Laurent P Lacroix

Behav Pharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats.
Claire Bloomfield, Sarah J French, Declan N C Jones, Charlie Reavill, Eric Southam

Synapse· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscarinic acetylcholine receptors as CNS drug targets.
Christopher J Langmead, Jeannette Watson, Charlie Reavill

Pharmacol Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole acts as a selective dopamine D2 receptor partial agonist.
Martyn Wood, Charlie Reavill

Expert Opin Investig Drugs· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
Jackie Cilia, Paula Hatcher, Charlie Reavill, Declan N C Jones

J Psychopharmacol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies towards the identification of a new generation of atypical antipsychotic agents.
Vincenzo Garzya, Ian T Forbes, Andrew D Gribble, Mike S Hadley, Andrew P Lightfoot, Charlie Reavill

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
Martyn D Wood, Claire Scott, Kirsten Clarke, Julie Westaway, Ceri H Davies, Charlie Reavill

Eur J Pharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data.
Claire Rourke, Kathryn R Starr, Charlie Reavill, Sue Fenwick, Kim Deadman

Psychopharmacology (Berl)· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist.
Jackie Cilia, Jane E Cluderay, Melanie J Robbins, Charlie Reavill, Eric Southam

Psychopharmacology (Berl)· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a mutant map of the mouse--new models of neurological, behavioural, deafness, bone, renal and blood disorders.
Sohaila Rastan, Tertius Hough, Amy Kierman, Rachel Hardisty, Alexandra Erven, Charlie Reavill

Genetica· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Gregor J Macdonald, Clive L Branch, Michael S Hadley, Christopher N Johnson, David J Nash, Charlie Reavill

J Med Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.
Jennifer C Roberts, Charlie Reavill, Simon Z East, Paul J Harrison, Sara Patel

Brain Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis